Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Cryoablation system to expand Boston Sci's global profile in interventional oncology

Sep. 18, 2019

By David Godkin

Triumvira Immunologics cleared in U.S and Canada to conduct TAC01-CD19 studies

June 19, 2019

Lanadelumab submissions in E.U. and Canada accepted for review

March 29, 2018

Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer

Feb. 5, 2018

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

Health Canada gives priority review status to ProMetic's NDS for Ryplazim

Oct. 20, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

Health Canada approves Maviret for chronic HCV in all major genotypes

Aug. 18, 2017

Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV

Aug. 18, 2017

Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease

May 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.